Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8592 USD | -0.14% | -16.58% | -33.40% |
25/04 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
25/04 | Transcript : OptiNose, Inc. - Special Call |
Sales 2024 * | 90.46M 7.55B | Sales 2025 * | 130M 10.87B | Capitalization | 97.12M 8.11B |
---|---|---|---|---|---|
Net income 2024 * | -30M -2.5B | Net income 2025 * | -13M -1.08B | EV / Sales 2024 * | 1.07 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
-3.3
x | P/E ratio 2025 * |
-9.82
x | Employees | 132 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.72% |
Latest transcript on OptiNose, Inc.
1 day | -0.14% | ||
1 week | -16.58% | ||
Current month | -41.15% | ||
1 month | -41.15% | ||
3 months | -39.49% | ||
6 months | -29.57% | ||
Current year | -33.40% |
Managers | Title | Age | Since |
---|---|---|---|
Ramy Mahmoud
CEO | Chief Executive Officer | 59 | 01/10/01 |
Chief Tech/Sci/R&D Officer | - | 01/17/01 | |
John C. Messina
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 01/17/01 | |
Sandra Helton
BRD | Director/Board Member | 74 | 22/18/22 |
Eric Bednarski
BRD | Director/Board Member | 53 | 10/21/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.8592 | -0.14% | 1,388,759 |
26/24/26 | 0.8604 | -4.93% | 3,147,264 |
25/24/25 | 0.905 | -2.19% | 23,397,083 |
24/24/24 | 0.9253 | -4.38% | 571,325 |
23/24/23 | 0.9677 | -6.05% | 671,645 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.40% | 97.12M | |
+26.47% | 664B | |
+24.88% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.96% | 234B | |
+4.58% | 199B | |
-9.86% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- OPTN Stock